Century Therapeutics Inc (IPSC) — Long-term Investment Intensity

Latest as of June 2025: 0.9%

Century Therapeutics Inc (IPSC) has a Long-term Investment Intensity of 0.9% as of June 2025. Long-term investments of $2.69 Million represent 0.9% of total assets of $284.69 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See what is Century Therapeutics Inc's book value for net asset value and shareholders' equity analysis.

LT Investment Intensity

0.9%
LT Investments / Total Assets

Long-term Investments

$2.69 Million
USD

Total Assets

$284.69 Million
USD

Country

USA
NASDAQ

Century Therapeutics Inc Long-term Investment Intensity (2019–2024)

This chart shows how Century Therapeutics Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the intensity stands at 0.9%, reflecting long-term investments of $2.69 Million against total assets of $284.69 Million USD. Also explore Century Therapeutics Inc assets under control for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Century Therapeutics Inc (2019–2024)

The table below presents the year-by-year Long-term Investment Intensity for Century Therapeutics Inc from 2019 to 2024, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see IPSC stock market capitalisation.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2024 8.7% $30.82 Million $353.22 Million ▼ -16.0 pp
2023 24.7% $89.10 Million $360.69 Million ▲ +14.0 pp
2022 10.7% $51.85 Million $486.54 Million ▼ -20.4 pp
2021 31.1% $135.91 Million $437.38 Million ▲ +30.1 pp
2020 1.0% $1.05 Million $106.78 Million ▼ -3.5 pp
2019 4.5% $4.08 Million $90.90 Million
pp = percentage points